Comprehensive drug discovery and development consulting from target identification through IND-enabling studies, tailored to your program's unique needs.
Eight core service areas covering the full spectrum of preclinical drug discovery and development.
End-to-end drug discovery support including target identification, target validation strategy, hit-to-lead campaigns, and candidate selection criteria. Leverage deep scientific expertise to de-risk your discovery programs.
Get started →Design and oversight of mechanistic cell-based assays, biochemical assays, receptor binding studies, functional assays, and ADME/tox screening panels. Expert data interpretation and SAR guidance.
Get started →Primary cell model development, human and animal tissue explant studies, PBMC-based immunology assays, and ex vivo disease-relevant model systems for mechanistic compound profiling.
Get started →Strategic design of efficacy and safety studies in relevant disease models. PK/PD analysis, biomarker-guided dose selection, and translational pharmacology bridging preclinical to clinical.
Get started →Bridging preclinical findings to clinical applications through biomarker strategy, patient stratification frameworks, clinical biomarker assay development, and translation packages for IND filing.
Get started →Expert guidance across diverse therapeutic modalities: small molecules, monoclonal antibodies, bispecifics, RNAi (siRNA/shRNA), antisense oligonucleotides, and gene therapy approaches.
Get started →Comprehensive landscape analyses, competitive positioning assessments, market opportunity evaluations, and scientific due diligence for investment decisions and partnership evaluations.
Get started →Portfolio strategy, program prioritization, go/no-go decision frameworks, scientific advisory board support, grant writing assistance, and research roadmap development.
Get started →Expert guidance and support at every stage of the drug discovery and development journey.
Bringing together scientific depth, industry experience, and strategic thinking.
20+ years of hands-on experience across leading academic institutions and biopharmaceutical companies, bringing hard-won insights to every engagement.
Deep mechanistic biology expertise combined with practical drug development knowledge, ensuring scientifically rigorous yet pragmatic recommendations.
Evidence-based decision frameworks that integrate current literature, proprietary data, and translational insights to maximize program success probability.
Track record of advancing programs from concept to clinical candidates, with a focus on sustainable, long-term value creation for clients and patients.
Schedule a free introductory call to discuss your program and how we can help.